The six-person urologist team from Essex Hudson will now be able to provide urologic oncology services in partnership with RWJBarnabas Health and the Rutgers Cancer Institute of New Jersey. They are: Robert Caruso; David Franzoni; Kuang-Yiao Hsieh; Salvatore A. Lombardo; Charles F. Rilli; and David S. Wu.
“The addition of Essex Hudson Urology to our Medical Group enhances the cancer services available to patients at Clara Maass Medical Center and Newark Beth Israel Medical Center, both RWJBarnabas Health facilities,” Steven K. Libutti, senior vice president of oncology services, RWJBarnabas Health, and director, Rutgers Cancer Institute of New Jersey, said. “With a focus on urologic oncology, their expertise will provide patients with advanced treatment options such as clinical trials, close to home.”
Essex Hudson specializes in comprehensive urologic care, including laparoscopic and robotic minimally invasive surgery, and treats a variety of conditions, including urinary stones, incontinence, urinary infections and urologic cancers.